Table of Contents

company-logo

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor, which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease; and SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. The company was incorporated in 2020 and is headquartered in Agoura Hills, California.

Acelyrin Dividend Announcement

• Acelyrin does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Acelyrin dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Acelyrin Dividend History

Acelyrin Dividend Yield

Acelyrin current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Acelyrin stock? Use our calculator to estimate your expected dividend yield:

Acelyrin Financial Ratios

P/E ratio-2.00
PEG ratio-0.02
P/B ratio1.06
ROE-81.29%
Payout ratio0.00%
Current ratio7.86
Quick ratio7.86
Cash Ratio1.55

Acelyrin Dividend FAQ

Does Acelyrin stock pay dividends?
Acelyrin does not currently pay dividends to its shareholders.
Has Acelyrin ever paid a dividend?
No, Acelyrin has no a history of paying dividends to its shareholders. Acelyrin is not known for its dividend payments.
Why doesn't Acelyrin pay dividends?
There are several potential reasons why Acelyrin would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Acelyrin ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Acelyrin has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Acelyrin a dividend aristocrat?
Acelyrin is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Acelyrin a dividend king?
Acelyrin is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Acelyrin a dividend stock?
No, Acelyrin is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Acelyrin stocks?
To buy Acelyrin you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Acelyrin stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.